Randomized controlled trials |
|
Efficacy of a once-monthly pill containing ibandronate and cholecalciferol on the levels of 25-hydroxyvitamin D and bone markers in postmenopausal women with osteoporosis |
2015;30(3):272–9 |
Effect of pitavastatin treatment on apoB-48 and Lp-PLA2 in patients with metabolic syndrome: substudy of prospective comparative clinical study evaluating the efficacy and safety of pitavastatin in patients with metabolic syndrome |
2016;31(1):120–6 |
Comparison of fixed versus calculated activity of radioiodine for the treatment of Graves disease in adults |
2016;31(1):168–73 |
Effects of vildagliptin or pioglitazone on glycemic variability and oxidative stress in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a 16-week, randomised, open label, pilot study |
2017;32(2):241–7 |
Articles using big data (nationwide population-based studies, registries, and regional cohorts) |
|
Adiposity in the relationship between serum vitamin D level and insulin resistance in middle-aged and elderly Korean adults: the Korea National Health and Nutrition Examination Survey 2008 |
2013;28(2):96–102 |
Age-related changes in the prevalence of osteoporosis according to gender and skeletal site: the Korea National Health and Nutrition Examination Survey 2008-2010 |
2013;28(3):180–91 |
Sex factors in the metabolic syndrome as a predictor of cardiovascular disease |
2014;29(4):522–9 |
Standardized thyroid cancer mortality in Korea between 1985 and 2010 |
2014;29(4):530–5 |
Associations between dietary acid-base load and cardiometabolic risk factors in adults: the Tehran Lipid and Glucose Study |
2015;30(2):201–7 |
Incidence and prevalence of overt hypothyroidism and causative diseases in Korea as determined using claims data provided by the Health Insurance Review and Assessment Service |
2015;30(3):288–96 |
Sugar-sweetened beverage consumption is associated with metabolic syndrome in Iranian adults: Tehran Lipid and Glucose Study |
2015;30(3):334–42 |
Characterization of patients with type 2 diabetes according to body mass index: Korea National Health and Nutrition Examination Survey from 2007 to 2011 |
2015;30(4):514–21 |
Trends in diabetes incidence in the last decade based on Korean National Health Insurance Claims Data |
2016;31(2):292–9 |
Urinary albumin excretion reflects cardiovascular risk in postmenopausal women without diabetes: the 2011 to 2013 Korean National Health and Nutrition Examination Survey |
2016;31(4):537–46 |
Thyroid stimulating hormone reference range and prevalence of thyroid dysfunction in the Korean population: Korea National Health and Nutrition Examination Survey 2013 to 2015 |
2017;32(1):106–14 |
Association between body weight changes and menstrual irregularity: the Korea National Health and Nutrition Examination Survey 2010 to 2012 |
2017;32(2):248–56 |
Prevalence and annual incidence of thyroid disease in Korea from 2006 to 2015: a nationwide population-based cohort study |
2018;33(2):260–7 |
Multicenter studies |
|
Characteristics of Korean patients with antithyroid drug-induced agranulocytosis: a multicenter study in Korea |
2015;30(4):475–80 |
Obesity and hyperglycemia in Korean men with Klinefelter syndrome: the Korean Endocrine Society Registry |
2016;31(4):598–603 |
Disease-specific mortality of differentiated thyroid cancer patients in Korea: a multicenter cohort study |
2017;32(4):434–41 |
Characteristics of Korean patients with primary adrenal insufficiency: a registry-based nationwide survey in Korea |
2017;32(4):466–74 |
Study protocol of multicenter prospective cohort study of active surveillance on papillary thyroid microcarcinoma (MAe-STro) |
2018;33(2):278–86 |
Prognosis of differentiated thyroid carcinoma with initial distant metastasis: a multicenter study in Korea |
2018;33(2):287–95 |
Articles on cost-effectiveness |
|
Cost-of-illness trends associated with thyroid disease in Korea |
2014;29(3):257–69 |
Economic evaluation of recombinant human thyroid stimulating hormone stimulation vs. thyroid hormone withdrawal prior to radioiodine ablation for thyroid cancer: the Korean perspective |
2015;30(4):531–42 |
Systematic reviews and meta-analyses |
|
Procalcitonin as marker of recurrent medullary thyroid carcinoma: a systematic review and meta-analysis |
2018;33(2):204–10 |
Comparisons of the effects of ezetimibe-statin combination therapy on major adverse cardiovascular events in patients with and without diabetes: a meta-analysis |
2018;33(2):219–27 |